Table 4.
Distribution of treatments administered in patients alive at day 7 after admission.
| Total n = 1011 |
In–Hospital Mortality, n (%) | p-Value | ||
|---|---|---|---|---|
| Variables [Number of Available Data] | n (%) | Yes n = 198 (20%) |
No n = 813 (80%) |
|
| LMWH (1008) | 500 (50%) | 107 (21%) | 393 (79%) | 0.140 |
| Steroids (970) | 305 (31%) | 62 (20%) | 243 (80%) | 0.777 |
| Antivirals (1007) | 408 (41%) | 66 (16%) | 342 (84%) | 0.022 |
| Lopinavir/Ritonavir (1007) | 251 (25%) | 40 (16%) | 211 (84%) | 0.086 |
| Darunavir /Ritonavir or Cobicistat (1007) | 158 (16%) | 26 (16%) | 132 (84%) | 0.269 |
| Remdesivir (882) | 7 (1%) | 1 (14%) | 6 (86%) | 0.701 |
| Hydroxychloroquine (1008) | 731 (73%) | 118 (16%) | 613 (84%) | <0.001 |
| Tocilizumab (884) | 90 (10%) | 13 (14%) | 77 (86%) | 0.196 |
LMWH, low molecular weight heparin, given for at least 72 h.